Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cyclerion Therapeutics (CYCN) Net Income (2019 - 2025)

Historic Net Income for Cyclerion Therapeutics (CYCN) over the last 7 years, with Q3 2025 value amounting to -$1.0 million.

  • Cyclerion Therapeutics' Net Income changed N/A to -$1.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$4.1 million, marking a year-over-year decrease of 3774.15%. This contributed to the annual value of $7.3 million for FY2023, which is 12837.57% up from last year.
  • Latest data reveals that Cyclerion Therapeutics reported Net Income of -$1.0 million as of Q3 2025.
  • In the past 5 years, Cyclerion Therapeutics' Net Income ranged from a high of $13.5 million in Q3 2023 and a low of -$16.2 million during Q2 2021
  • Its 5-year average for Net Income is -$6.0 million, with a median of -$5.2 million in 2022.
  • Per our database at Business Quant, Cyclerion Therapeutics' Net Income surged by 32128.43% in 2023 and then plummeted by 2080.92% in 2025.
  • Over the past 5 years, Cyclerion Therapeutics' Net Income (Quarter) stood at -$14.3 million in 2021, then surged by 79.82% to -$2.9 million in 2022, then skyrocketed by 565.74% to $13.5 million in 2023, then plummeted by 110.27% to -$1.4 million in 2024, then rose by 27.31% to -$1.0 million in 2025.
  • Its last three reported values are -$1.0 million in Q3 2025, -$1.7 million for Q2 2025, and -$1.5 million during Q1 2025.